We provide the evidence base for our innovative biomarkers
Our medical affairs team bridges between our activities in research & development (R&D) and in marketing working closely with regulatory affairs. While R&D identifies new biomarker candidates and develops the biomarker assays, the colleagues in medical affairs provide the clinical evidence for clinical utility and the post market support for our assays.
To generate the evidence on safety and effectiveness of our B·R·A·H·M·S Biomarker assays we run clinical trials worldwide and ensure the dissemination of scientific information at major conferences and publications in peer-reviewed journals. Our close collaboration with clinical thought leaders at well-known institutes and universities drives the innovation in our clinical projects. We act as advisors and consultants for many other functions including business development and sales across the complete product life cycle management to help achieve our overall goals and objectives.